IMV102

· Suzhou Immunofoco Biotechnology Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMV102, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma [EARLY_Phase 1]